SLC2A1 and breast cancer: Early on, Chen et al. [44] reported that also in breast cancer the important portal protein of glucose uptake, Glucose transporter 1 (GLUT1) was proved to be a direct target of miR-22, and dysregulated miR-22 expression functioned at the suppression of cancer cell proliferation and invasion.